TCTC Holdings’s GSK GSK Stock Holding History

TCTC Holdings’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,668	Closed	-$81.8K	–	356
2025 Q4	$81.8K	Hold	1,668	–	–	﹤0.01%	292
2025 Q3	$72K	Hold	1,668	–	–	﹤0.01%	298
2025 Q2	$64.1K	Hold	1,668	–	–	﹤0.01%	315
2025 Q1	$64.6K	Sell	1,668 -510	-23%	-$18.7K	﹤0.01%	301
2024 Q4	$73.7K	Buy	2,178 +510	+31%	+$18.4K	﹤0.01%	285
2024 Q3	$68.2K	Hold	1,668	–	–	﹤0.01%	283
2024 Q2	$64.2K	Hold	1,668	–	–	﹤0.01%	289
2024 Q1	$71.5K	Hold	1,668	–	–	﹤0.01%	270
2023 Q4	$61.8K	Buy	1,668 +1,108	+198%	+$39.8K	﹤0.01%	283
2023 Q3	$20.3K	Hold	560	–	–	﹤0.01%	322
2023 Q2	$20K	Sell	560 -253	-31%	-$9.07K	﹤0.01%	323
2023 Q1	$28.9K	Hold	813	–	–	﹤0.01%	322
2022 Q4	$28.6K	Hold	813	–	–	﹤0.01%	309
2022 Q3	$24K	Sell	813 -1	-0.1%	-$38	﹤0.01%	303
2022 Q2	$44K	Hold	814	–	–	﹤0.01%	279
2022 Q1	$44K	Hold	814	–	–	﹤0.01%	285
2021 Q4	$45K	Hold	814	–	–	﹤0.01%	311
2021 Q3	$39K	Hold	814	–	–	﹤0.01%	327
2021 Q2	$40K	Hold	814	–	–	﹤0.01%	287
2021 Q1	$36K	Sell	814 -830	-50%	-$37.7K	﹤0.01%	290
2020 Q4	$76K	Hold	1,644	–	–	﹤0.01%	224
2020 Q3	$77K	Hold	1,644	–	–	﹤0.01%	217
2020 Q2	$84K	Buy	+1,644	New	+$84.3K	0.01%	209

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

TCTC Holdings's GSK Position: Q1 2026 in Review

TCTC Holdings sold out of GSK (GSK) in Q1 2026, closing a stake of 1,668 shares — an estimated $81.8K sold.

TCTC Holdings first reported a position in GSK in Q2 2020 and held it in 23 quarters. The position peaked at $84K in Q2 2020. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

TCTC Holdings reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
TCTC Holdings sold 1,668 GSK shares in Q1 2026, an estimated $81.8K.
TCTC Holdings first reported a position in GSK in Q2 2020 and held it in 23 quarters.
TCTC Holdings's GSK position peaked at $84K in Q2 2020.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on TCTC Holdings's 13F filing for Q1 2026, filed 7 May 2026.